Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic.
作者信息
Chhatwal Jagpreet, Postma Maarten J
机构信息
Institute for Technology Asssessment, Massachusetts General Hospital, Harvard Medical school, Boston, MA, USA.
Department of Health Sciences, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands and Department of Economics, Econometrics & Finance, University of Groningen, Faculty of Economics & Business, Groningen, The Netherlands.
出版信息
Value Health. 2021 May;24(5):605-606. doi: 10.1016/j.jval.2021.03.002. Epub 2021 Apr 16.
Abstract
摘要
相似文献
1
Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic.应对2019年冠状病毒大流行干预措施的卫生经济学
Value Health. 2021 May;24(5):605-606. doi: 10.1016/j.jval.2021.03.002. Epub 2021 Apr 16.
2
The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19).卫生经济学与结果研究在应对2019冠状病毒病（COVID-19）中的作用
Value Health. 2020 Nov;23(11):1403-1404. doi: 10.1016/j.jval.2020.09.009. Epub 2020 Oct 13.
3
The find of COVID-19 vaccine: Challenges and opportunities.COVID-19 疫苗的发现：挑战与机遇。
J Infect Public Health. 2021 Mar;14(3):389-416. doi: 10.1016/j.jiph.2020.12.025. Epub 2020 Dec 30.
4
"Missed" Information: A Moral Failing that Erodes Efforts to Tackle the COVID-19 Pandemic.
Int J Public Health. 2022 Jan 14;66:1604667. doi: 10.3389/ijph.2021.1604667. eCollection 2021.
5
Schwartz rounds for healthcare personnel in coping with COVID-19 pandemic.面向医护人员的施瓦茨圆桌会议：应对新冠疫情
Postgrad Med J. 2020 Jul;96(1137):425. doi: 10.1136/postgradmedj-2020-137806. Epub 2020 Apr 28.
6
Comparison of telehealth and traditional face-to-face model during COVID-19 pandemic.COVID-19大流行期间远程医疗与传统面对面模式的比较。
Med Clin (Barc). 2020 Oct 23;155(8):361-362. doi: 10.1016/j.medcli.2020.06.024. Epub 2020 Jul 9.
7
COVID-19 - how a pandemic reveals that everything is connected to everything else.新冠疫情——一场大流行如何揭示万物皆相互关联。
J Eval Clin Pract. 2020 Oct;26(5):1361-1367. doi: 10.1111/jep.13419. Epub 2020 Jul 6.
8
Improving knowledge and innovations to tackle Covid-19 pandemic.提高应对新冠疫情的知识水平和创新能力。
Scott Med J. 2020 Nov;65(4):107-108. doi: 10.1177/0036933020963315.
9
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.新型冠状病毒病 2019（COVID-19）大流行期间癌症患者管理的实用方法：国际协作组。
Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27.
10
Using Insights from Behavioral Economics to Mitigate the Spread of COVID-19.利用行为经济学的洞察力来减轻 COVID-19 的传播。
Appl Health Econ Health Policy. 2020 Jun;18(3):345-350. doi: 10.1007/s40258-020-00595-4.
引用本文的文献
1
COVID-19 Health Economics: Looking Back and Scoping the Future.COVID-19健康经济学：回顾与展望未来
Value Health. 2022 May;25(5):695-696. doi: 10.1016/j.jval.2022.03.008. Epub 2022 Apr 4.
本文引用的文献
1
Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands.社会影响是荷兰民众接受 2019 年冠状病毒病（COVID-19）数字接触者追踪应用的主要因素。
Value Health. 2021 May;24(5):658-667. doi: 10.1016/j.jval.2021.01.001. Epub 2021 Mar 10.
2
Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study.在 2019 冠状病毒病危机及以后，当外科能力稀缺时尽量减少人群健康损失：建模研究。
Value Health. 2021 May;24(5):648-657. doi: 10.1016/j.jval.2020.12.010. Epub 2021 Mar 5.
3
Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs.评估 2019 年冠状病毒病（COVID-19）药物的不精确试验的统计决策特性。
Value Health. 2021 May;24(5):641-647. doi: 10.1016/j.jval.2020.11.019. Epub 2021 Mar 9.
4
Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States.美国每预防一例 COVID-19 感染可避免的质量调整生命年损失。
Value Health. 2021 May;24(5):632-640. doi: 10.1016/j.jval.2020.11.013. Epub 2021 Mar 8.
5
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?如何为冠状病毒病（COVID-19）疫苗买单？
Value Health. 2021 May;24(5):625-631. doi: 10.1016/j.jval.2020.12.008. Epub 2021 Feb 19.
6
Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies.疾病负担归因于中国第一波 COVID-19 疫情，以及时机对限制流动政策成本效益的影响。
Value Health. 2021 May;24(5):615-624. doi: 10.1016/j.jval.2020.12.009. Epub 2021 Feb 21.
7
Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis.建模社交隔离策略以预防 SARS-CoV-2 在以色列的传播：成本效益分析。
Value Health. 2021 May;24(5):607-614. doi: 10.1016/j.jval.2020.09.013. Epub 2020 Dec 9.
8
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study.愿意在新冠病例、社交隔离限制和经济影响之间权衡取舍：一项全美范围的美国研究。
Value Health. 2020 Nov;23(11):1438-1443. doi: 10.1016/j.jval.2020.07.003. Epub 2020 Sep 4.
9
Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom.新冠大流行的成本：英国假设抑制政策的探索性经济评估。
Value Health. 2020 Nov;23(11):1432-1437. doi: 10.1016/j.jval.2020.07.001. Epub 2020 Aug 27.
10
The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable.使潜在的2019冠状病毒病治疗方法可及且可负担的经济与公共卫生必要性。
Value Health. 2020 Nov;23(11):1427-1431. doi: 10.1016/j.jval.2020.04.1824. Epub 2020 May 21.
Zotero 插件